Roopa Industries Limited (BOM:530991)

India · Delayed Price · Currency is INR

46.90

+1.00 (2.18%)

At close: Oct 1, 2026

Market Cap	368.89M -12.9%
Revenue (ttm)	1.26B +1.8%
Net Income	1.28M -93.7%
EPS	0.20 -92.2%
Shares Out	7.87M
PE Ratio	231.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,498
Open	47.50
Previous Close	45.90
Day's Range	43.78 - 48.50
52-Week Range	38.10 - 63.40
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenylphosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. It serves pharma industry. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India. [Read more]

Industry Chemicals and Allied Products

Founded 1985

Employees 56

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530991

Full Company Profile

Financial Performance

In fiscal year 2026, Roopa Industries's revenue was 1.28 billion, an increase of 5.30% compared to the previous year's 1.21 billion. Earnings were 831,000, a decrease of -95.92%.

Financial Statements